[1]
Sandhiya J et al. 2026. A NEXT-GENERATION ARTIFICIAL INTELLIGENCE-DESIGNED ANTIBODY AGAINST TUMOR NECROSIS FACTOR-LIKE LIGAND 1A FOR INFLAMMATORY BOWEL DISEASE: CURRENT STATUS AND FUTURE PERSPECTIVES. The Bioscan. 21, 4 (Oct. 2026), 185–217.